Reliant AI
Reliant AI is a life sciences-focused AI company that provides an AI-powered data manipulation and verification platform called Reliant Tabular. The platform transforms unstructured scientific data into structured, actionable insights, enabling faster and more accurate evidence synthesis, competitive landscaping, and literature reviews. Reliant AI's technology leverages specialized large language models and database-scanning algorithms to deliver results significantly faster and with fewer errors than manual methods or general AI tools. The company serves biopharma and life sciences professionals, helping them make confident, evidence-backed decisions by aggregating and analyzing over 38 million scientific publications, conference abstracts, and clinical trials. Reliant AI operates globally with offices in Montreal, Berlin, and Denver, and has raised $11.3M in seed funding. The company is recognized for its innovation in AI applications for pharma and life sciences, with a team of AI researchers and industry experts from Google, DeepMind, and EY Parthenon.
Reliant AI
Reliant AI is a life sciences-focused AI company that provides an AI-powered data manipulation and verification platform called Reliant Tabular. The platform transforms unstructured scientific data into structured, actionable insights, enabling faster and more accurate evidence synthesis, competitive landscaping, and literature reviews. Reliant AI's technology leverages specialized large language models and database-scanning algorithms to deliver results significantly faster and with fewer errors than manual methods or general AI tools. The company serves biopharma and life sciences professionals, helping them make confident, evidence-backed decisions by aggregating and analyzing over 38 million scientific publications, conference abstracts, and clinical trials. Reliant AI operates globally with offices in Montreal, Berlin, and Denver, and has raised $11.3M in seed funding. The company is recognized for its innovation in AI applications for pharma and life sciences, with a team of AI researchers and industry experts from Google, DeepMind, and EY Parthenon.